Good news everyone! The World Health Organization (WHO) and European Medicines Agency (EMA) has finished the Phase 3 trial of the RTS,S (Mosquirix) or the world’s first malaria vaccine.
Above all, we know that Malaria is one of the life-threatening diseases today. This disease is caused by parasites that are transferred to people with the bites of an infected female mosquito.
In fact, 400,00 people globally each year are dying from Malaria especially for children. To be exact, every 2 minutes a child dies from malaria according to WHO.
That’s why the development of a malaria vaccine is indeed important even it’s quite difficult.
But thanks to the efforts of WHO and EMA, we now the chance to stop this epidemic disease, especially in Africa.
Moreover, the first malaria vaccine has undergone trial and given to three countries in Africa including Kenya.
Certainly, the vaccine is the most advanced serum against the deadliest form of human malaria, Plasmodium falciparum.
More than 300,000 children in their country will receive the vaccine over the next 3 years.
“The children are the extremely defenseless people when it comes to this deadly disease, malaria. That’s why protecting them with this vaccine will have a huge impact in preventing the disease.”Dr. Richard Mihigo, WHO’s coordinator of immunization and vaccine development program.
The world’s first malaria vaccine is indeed a game-changer in the prevention of this deadly disease.
We hope that there will be more vaccines and cures that WHO will create for our incurable diseases we have today. Dark Accent 3;